Skin Cancer News and Research

Latest Skin Cancer News and Research

Epigallocatechin gallate can shrink cancerous tumours

A compound found in green tea could be a weapon in treatments for tackling cancer, according to newly-published research at the University of Strathclyde in Glasgow, Scotland.

23 Aug 2012

Study demonstrates how Elesclomol blocks oxidative phosphorylation in melanoma

A laboratory study led by UNC medical oncologist Stergios Moschos, MD, demonstrates how a new targeted drug, Elesclomol, blocks oxidative phosphorylation, which appears to play essential role in melanoma that has not been well-understood. Elesclomol (Synta Pharmaceuticals, Lexington, MA) was previously shown to have clinical benefit only in patients with normal serum lactate dehydrogenase (LDH), a laboratory test routinely used to assess activity of disease.

18 Aug 2012

Inhibiting over-production of Panx1 protein can treat melanoma

New research from Western University, Canada, has identified a potential new target for the treatment of melanoma, the deadliest of all skin cancers. Silvia Penuela and Dale Laird discovered a new channel-forming protein called Pannexin (Panx1) that is expressed in normal levels on the surface of healthy skin cells.

16 Aug 2012

Tips to prevent aging

Getting better results from your anti-aging products can be as easy as following simple tips from dermatologists.

15 Aug 2012

UV dosimeter technology helps prevent over-exposure to the sun

A monitor developed at the University of Strathclyde in Glasgow, Scotland, to help prevent over-exposure to the sun is set to go on the market as part of a new spinout company.

7 Aug 2012

Research supports ability of some herbal agents against sunburn

Recent research supports the ability of some herbal agents, taken orally or applied topically, to prevent sunburn and limit the damage caused by excessive exposure to ultraviolet (UV) light.

1 Aug 2012

Young women with indoor tanning habits frequently experience sunburn

Controversy remains over the risks involved with indoor tanning, especially in children and young adults. Since sunburn serves as a marker for excessive and skin-cell damaging ultraviolet (UV) exposure -- which can eventually lead to the development of skin cancer -- investigators at The Cancer Institute of New Jersey (CINJ) took a closer look at a college-aged sample of females and their indoor tanning habits.

31 Jul 2012

Photoacoustics limited in its ability to identify multiple types of cancer

One person dies every hour from melanoma skin cancer in the United States, according to the American Cancer Society. A technique, known as photoacoustics, can find some forms of melanoma even if only a few cancerous cells exist, but a recent study by MU researchers found that the technique was limited in its ability to identify other types of cancer.

31 Jul 2012

Sirolimus has anti-skin cancer effect in kidney transplant patients

Switching from calcineurin inhibitors to a sirolimus-containing immunosuppression regimen may help reduce the incidence of secondary skin cancer after kidney transplantation, suggests research published in TheNew England Journal of Medicine.

27 Jul 2012

MASL protein from plant's seeds may halt spread of melanoma

An international team of scientists led by Gary Goldberg, PhD, of the University of Medicine and Dentistry of New Jersey-School of Osteopathic Medicine (UMDNJ-SOM), has found that a protein from the seeds of a plant used for centuries in traditional medicines may be able to halt the spread of melanoma, a lethal form of skin cancer.

25 Jul 2012

Sunbed users at a 20% increased relative risk of skin cancer

Of 63,942 new cases of cutaneous melanoma (a form of skin cancer) diagnosed each year in Europe an estimated 3,438 (5.4%) are related to sunbed use. Sunbed users are at a 20% increased relative risk of skin cancer compared with those who have never used a sunbed. This risk doubles if they start before the age of 35 and experts warn that “tougher actions” are needed to reduce this risk.

25 Jul 2012

Study identifies MDM4 protein as promising target for treatment of melanoma

A melanoma is a malignant form of skin cancer and is one of the most aggressive types of tumors there is. Treatment is particularly difficult, because melanomas are usually resistant against conventional chemotherapy treatments.

24 Jul 2012

UV induction of melanin is directly involved in melanoma formation

A new study conducted by GW School of Medicine and Health Sciences (SMHS) researchers Edward C. De Fabo, Ph.D., Frances P. Noonan, Ph.D., and Anastas Popratiloff, M.D., Ph.D., has been published in the journal Nature Communications. Their paper, entitled "Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment," was published in June 2012.

24 Jul 2012

Sandoz acquires Fougera Pharmaceuticals

Sandoz has completed its USD 1.525 billion acquisition of specialty US dermatology company Fougera Pharmaceuticals on a cash and debt free basis.

23 Jul 2012

Targeted regulation of microRNA-125b may lead to effective prostate cancer therapies

A small, naturally occurring nucleic acid sequence, called a microRNA, known to regulate a number of different cancers, appears to alter the activity of the androgen receptor, which plays a critical role in prostate cancer.

18 Jul 2012

Chicago-area dermatologists to offer free skin cancer screenings

Chicago-area dermatologists will offer free skin cancer screenings to sun worshipers at one of the city's most popular beach this summer. The screenings will take place from 10 a.m. - 4 p.m. on Saturday, Aug. 4, and Sunday, Aug. 5, at North Avenue Beach.

14 Jul 2012

DRCRF names 21 new Damon Runyon Fellows

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 21 new Damon Runyon Fellows at its spring Fellowship Award Committee review.

11 Jul 2012

Caffeine combats skin cancer risk

Drinking three or more cups of caffeinated coffee a day can significantly reduce a person’s risk for basal cell carcinoma, show study findings.

10 Jul 2012

Researchers discover mechanism that favours disappearance and inhibition of SCC development

Skin squamous cell carcinoma (SCC) is a subtype of very aggressive skin cancers that usually develops in sunexposed body regions, but can also affect a large number of organs such as the bladder, esophagus, lungs etc. However, little is known about the biology of these cells, which consequently makes difficult the generation of new specific therapies; actually, the standard treatments are based on surgery and subsequent radiotherapy.

10 Jul 2012

Sox10 gene plays a central role in melanoma

Black skin cancer, also known as melanoma, is particularly aggressive and becoming increasingly common in Switzerland. Despite intensive research, however, there is still no treatment. Researchers from the University of Zurich have now discovered a gene that plays a central role in black skin cancer. Suppressing this gene in mice inhibits the development of melanoma and its proliferation - a discovery that could pave the way for new forms of therapy.

10 Jul 2012